Cited by 222Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.

Coronary Artery Disease and Diabetes Mellitus

Open access

Aronson, Doron, Edelman, Elazer R.·2014·Cardiology Clinics

DOI 10.1016/j.ccl.2014.04.001PMC PMC4672945

Open this paper in CoChat — free account

Abstract

Diabetes mellitus (DM) is a major risk factor for cardiovascular disease. Near-normal glycemic control does not reduce cardiovascular events. For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the superiority of coronary artery bypass grafting over multivessel percutaneous coronary intervention in patients with treated DM. However, selection of the optimal myocardial revascularization strategy requires a multidisciplinary team approach ('heart team'). This review summarizes the current evidence regarding the effectiveness of various medical therapies and revascularization strategies in patients with DM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccl.2014.04.001

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Guidelines on myocardial revascularization
Wijns, W. C., Kolh, P. H., Danchin, N., Mario, C. D., Falk, V., Folliguet, T. A., Garg, S., Huber, K., James, S. K., Knuuti, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,228
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
Iakovou, I. P. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,136
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805796 · Cited by 1,939
Strategies for Multivessel Revascularization in Patients with Diabetes
Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211585 · Cited by 1,922
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
Mohr, F. W., Morice, M., Kappetein, A. P., Feldman, T. E., Ståhle, E., Colombo, A., Mack, M. J., Holmes, D. R., Morel, M.-A., Dyck, N. V., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60141-5 · Cited by 1,788
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Curtis, P. S., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60953-3 · Cited by 1,393
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390
Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ahxt-ag78 · Cited by 1,037
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,011
Untitled work
(1970) · PubMed · Cited by 976
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion
Nikolaidis, L. A., Mankad, S., Sokos, G. G., Miske, G., Shah, A., Elahi, D., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000120505.91348.58 · Cited by 901
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
Nesto, R. W., Bell, D. S. H., Bonow, R. O., Fonseca, V. A., Grundy, S. M., Horton, E. S., Winter, M. L., Porte, D., Semenkovich, C. F., Smith, S. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 831
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial
Young, L. H., Wackers, F. J. T., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., et al. (2009) · JAMA · doi:10.1001/jama.2009.476 · Cited by 809
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–Thrombolysis in Myocardial Infarction 38
Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W. A., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.791061 · Cited by 754
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
Hlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E. H., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M. D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 729
Diabetes and mortality following acute coronary syndromes
Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., & Antman, E. M. (2007) · JAMA · doi:10.1001/jama.298.7.765 · Cited by 716
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes
Kosiborod, M., Rathore, S. S., Inzucchi, S. E., Masoudi, F. A., Wang, Y., Havranek, E. P., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/circulationaha.104.517839 · Cited by 666
Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
Preis, S. R., Hwang, S., Coady, S., Pencina, M. J., D’Agostino, R. B., Savage, P. J., Levy, D. A., & Fox, C. S. (2009) · Circulation · doi:10.1161/circulationaha.108.829176 · Cited by 619
Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease: The Bypass Angioplasty Revascularization Investigation (BARI)
Investigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee, R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00336 · Cited by 609
Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery
Gandhi, G. Y., Nuttall, G. A., Abel, M., Mullany, C. J., Schaff, H. V., O’Brien, P. C., Johnson, M. G., Williams, A. R., Cutshall, S. M., Mundy, L. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-4-200702200-00002 · Cited by 603
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
Schramm, T. K., Gislason, G., Køber, L., Rasmussen, S., Rasmussen, J. N., Abildstrom, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M. M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.720847 · Cited by 540
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
Kapur, A., Hall, R., Malik, I., Qureshi, A., Butts, J. N., de Belder, M. D., Baumbach, A., Angelini, G., de Belder, A. D., Oldroyd, K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.014 · Cited by 497
Hyperglycemia and Acute Coronary Syndrome
DEEDWANIA, P. C., Kosiborod, M., Barrett, E. J., Ceriello, A., Isley, W. L., Mazzone, T., & Raskin, P. (2008) · Circulation · doi:10.1161/circulationaha.107.188629 · Cited by 495
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes
Rask‐Madsen, C., & King, G. L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0366 · Cited by 490
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice
Wenaweser, P., Daemen, J., Zwahlen, M., van Domburg, R., Jüni, P., Vaina, S., Hellige, G., Tsuchida, K., Morger, C., Boersma, E. H., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.006 · Cited by 480
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Skyler, J. S., Bergenstal, R. M., Bonow, R. O., Buse, J. B., DEEDWANIA, P. C., Gale, E. A., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P. D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.008 · Cited by 473
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization
Patel, M. R., DEHMER, G. J., Hirshfeld, J. W., Smith, P. K., & Spertus, J. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.005 · Cited by 452
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization
CORONARY REVASCULARIZATION WRITING GROUP, Patel, M. R., DEHMER, G. J., Hirshfeld, J. W., Smith, P. K., & Spertus, J. A. (2009) · Circulation · doi:10.1161/circulationaha.108.191768 · Cited by 449
The Final 10-Year Follow-Up Results From the BARI Randomized Trial
(2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.048 · Cited by 447
Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J. M., & Stehouwer, C. D. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.20 · Cited by 440
Association of Hypoglycemia and Cardiac Ischemia
Desouza, C., Salazar, H., Cheong, B., Murgo, J., & Fonseca, V. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1485 · Cited by 406
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†
Kappetein, A. P., Head, S. J., Morice, M., BANNING, A. P., Serruys, P. W. J. C., Mohr, F., Dawkins, K. D., Mack, M. J., & on behalf of the SYNTAX Investigators (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt017 · Cited by 392
Hypoglycemia and cardiovascular risks
Frier, B. M., Schernthaner, G., & Heller, S. R. (2011) · Diabetes Care · doi:10.2337/dc11-s220 · Cited by 381
Intensive Glycemic Control in the ACCORD and ADVANCE Trials
Dluhy, R. G., & McMahon, G. T. (2008) · New England Journal of Medicine · doi:10.1056/nejme0804182 · Cited by 378
Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction
Kosiborod, M. (2009) · JAMA · doi:10.1001/jama.2009.496 · Cited by 362
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Skyler, J. S., Bergenstal, R. M., Bonow, R. O., Buse, J. B., DEEDWANIA, P. C., Gale, E. A., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.191305 · Cited by 346
Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., & Shekelle, P. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 333
Potential mechanisms promoting restenosis in diabetic patients
Aronson, D., Bloomgarden, Z. T., & Rayfield, E. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00496-3 · Cited by 328
Self-citation
Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice
Urban, P. M., Gershlick, A., Guagliumi, G., Guyon, P., Lotan, C., Schöfer, J., Seth, A., Sousa, J. E., Wijns, W. C., Berge, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.104.532242 · Cited by 321
The Platelet in Diabetes
Colwell, J. A., & Nesto, R. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2181 · Cited by 311
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
McMurray, J. J. V., Gerstein, H. C., Holman, R. R., & Pfeffer, M. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70031-2 · Cited by 305
Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction
Aronson, D., Rayfield, E. J., & Chesebro, J. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-4-199702150-00006 · Cited by 304
Self-citation
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
Preis, S. R., Pencina, M. J., Hwang, S., D’Agostino, R. B., Savage, P. J., Levy, D. A., & Fox, C. S. (2009) · Circulation · doi:10.1161/circulationaha.108.846519 · Cited by 292
Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease
Banning, A. P., Westaby, S., Morice, M.-C., Kappetein, A. P., Mohr, F. W., Berti, S., Glauber, M., Kellett, M. A., Kramer, R. S., Leadley, K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.057 · Cited by 290
Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation
Kimura, T., Morimoto, T., Nakagawa, Y., Kawai, K., Miyazaki, S., Muramatsu, T., Shiode, N., Namura, M., Sone, T., Oshima, S., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.046599 · Cited by 268
The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction
Chaitman, B. R., Hardison, R. M., Adler, D., Gebhart, S., Grogan, M., Ocampo, S., Sopko, G., Ramires, J. A., Schneider, D., Frye, R. L., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.913111 · Cited by 263
Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting
Sokos, G. G., Bölükoglu, H., German, J., Hentosz, T. M., Magovern, G. J., Maher, T. D., Dean, D. A., Bailey, S. H., MARRONE, G. C., Benckart, D. H., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.022 · Cited by 253
Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction
Dangas, G., Caixeta, A. M., Mehran, R., Parise, H., Lansky, A. J., Cristea, E., Brodie, B. R., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.981688 · Cited by 248
Radial Artery Grafts vs Saphenous Vein Grafts in Coronary Artery Bypass Surgery
Goldman, S. (2011) · JAMA · doi:10.1001/jama.2010.1976 · Cited by 240
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization
Patel, M. R., DEHMER, G. J., Hirshfeld, J. W., Smith, P. K., Spertus, J. A., Masoudi, F. A., Brindis, R. G., Beckman, K. J., Chambers, C. E., Ferguson, T. B., et al. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21964 · Cited by 226
Late Coronary Stent Thrombosis
Windecker, S., & Meier, B. (2007) · Circulation · doi:10.1161/circulationaha.106.683995 · Cited by 226
Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients
Machecourt, J., Danchin, N., Lablanche, J. M., Fauvel, J. M., Bonnet, J., Marlière, S., Foote, A., Quesada, J. L., Eltchaninoff, H., & Vanzetto, G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.051 · Cited by 207
The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience
Hiatt, W. R., Kaul, S., & Smith, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1309610 · Cited by 204
Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus
Stone, G. W., Kedhi, E., Kereiakes, D. J., Parise, H., Fahy, M. P., Serruys, P. W. J. C., & Smits, P. C. (2011) · Circulation · doi:10.1161/circulationaha.111.031070 · Cited by 201
Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus
Takagi, T., Akasaka, T., Yamamuro, A., Honda, Y., Hozumi, T., Morioka, S., & Yoshida, K. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00895-0 · Cited by 187
Glycemic Management of Type 2 Diabetes Mellitus
Ismail‐Beigi, F. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1013127 · Cited by 186
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents
Aoki, J., Lansky, A. J., Mehran, R., Moses, J. W., Bertrand, M. E., McLaurin, B. T., Cox, D. A., Lincoff, A. M., Ohman, E. M., White, H. D., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.804203 · Cited by 183
U-Shaped Relationship of Blood Glucose With Adverse Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction
Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., D, E. B. M., & Gibson, C. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.052 · Cited by 179
The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction
Detre, K. M., Lombardero, M. S., Brooks, M. M., Hardison, R. M., Holubkov, R., Sopko, G., Frye, R. L., & Chaitman, B. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421401 · Cited by 171
Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation
Marx, N., Wöhrle, J., Nusser, T., Walcher, D., Rinker, A., Hombach, V., Köenig, W., & Höher, M. (2005) · Circulation · doi:10.1161/circulationaha.105.535484 · Cited by 165
Severe Hypoglycemia Predicts Mortality in Diabetes
Cryer, P. E. (2012) · Diabetes Care · doi:10.2337/dc12-0749 · Cited by 163
Coronary Heart Disease in Patients With Diabetes
Berry, C., Tardif, J., & Bourassa, M. G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.045 · Cited by 151
Stent Thrombosis in Sweden
Lagerqvist, B., CARLSSON, J., Fröbert, O., Lindbäck, J., Scherstén, F., Stenestrand, U., & James, S. K. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.844985 · Cited by 127
Sulfonylurea KATPBlockade in Type II Diabetes and Preconditioning in Cardiovascular Disease
Engler, R. L., & Yellon, D. M. (1996) · Circulation · doi:10.1161/01.cir.94.9.2297 · Cited by 124
Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease
Dagenais, G. R., Lu, J., Faxon, D. P., Kent, K. M., Lago, R. M., Lezama, C., Hueb, W. A., Weiss, M. B., Slater, J. N., Frye, R. L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.978247 · Cited by 122
Current concepts on coronary revascularization in diabetic patients
Roffi, M., Angiolillo, D. J., & Kappetein, A. P. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr305 · Cited by 107
Serious Cardiovascular Outcomes in Diabetes
Yakubovich, N., & Gerstein, H. C. (2011) · Circulation · doi:10.1161/circulationaha.110.948489 · Cited by 104
Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI)
Schwartz, L., Kip, K. E., Frye, R. L., Alderman, E. L., Schaff, H. V., & Detre, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000038885.94771.43 · Cited by 103
Coronary Artery Revascularization in Patients With Diabetes Mellitus
Armstrong, E. J., Rutledge, J. C., & Rogers, J. H. (2013) · Circulation · doi:10.1161/circulationaha.113.002114 · Cited by 99
Effect of Skeletonization of the Internal Thoracic Artery for Coronary Revascularization on the Incidence of Sternal Wound Infection
Saso, S., James, D. R. C., Vecht, J. A., Kidher, E. S., Kokotsakis, J. N., Malinovski, V., Rao, C., Darzi, A. W., Anderson, J. R., & Athanasiou, T. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.08.018 · Cited by 94
Clinical Outcome of Patients With and Without Diabetes Mellitus After Percutaneous Coronary Intervention With the Resolute Zotarolimus-Eluting Stent
Silber, S., Serruys, P. W. J. C., Leon, M. B., Meredith, I. T., Windecker, S., Neumann, F., Belardi, J., Widimský, P., Massaro, J., Novack, V., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.11.006 · Cited by 91
Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting
Aronson, D., & Edelman, E. R. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9135-3 · Cited by 90
Self-citation
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
Hoogwerf, B. J., Waness, A., Cressman, M. D., Canner, J., CAMPEAU, L. A., Domański, M., Geller, N. L., Herd, A. J., Hickey, A., Hunninghake, D. B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1289 · Cited by 84
Risk factors for wound infection after off-pump coronary artery bypass grafting: Should bilateral internal thoracic arteries be harvested in patients with diabetes?
Nakano, J., Okabayashi, H., Hanyu, M., Soga, Y., Nomoto, T., Arai, Y., Matsuo, T., Kai, M., & Kawatou, M. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.11.008 · Cited by 73
5-Year Follow-Up of Coronary Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease
Onuma, Y., Wykrzykowska, J. J., Garg, S., Vranckx, P., & Serruys, P. W. J. C. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.12.004 · Cited by 71
Acute Hypoglycemia Decreases Myocardial Blood Flow Reserve in Patients With Type 1 Diabetes Mellitus and in Healthy Humans
Rana, O., Byrne, C. D., Kerr, D. E., Coppini, D., Zouwail, S., Senior, R., Begley, J., Walker, J. J., & Greaves, K. (2011) · Circulation · doi:10.1161/circulationaha.110.992297 · Cited by 64
The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion.
Libby, P., Maroko, P. R., & Braunwald, E. (1975) · Circulation · doi:10.1161/01.cir.51.4.621 · Cited by 63
Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients.
Gum, P., O’Keefe, J. H., Borkon, A. M., Spertus, J. A., Tm, B., Jp, M., Sherwani, K., Vacek, J. L., & Bd, M. (1997) · PubMed · Cited by 63
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Stenestrand, U., James, S. K., Lindbäck, J., Fröbert, O., CARLSSON, J., Scherstén, F., Nilsson, T., Lagerqvist, B., & for the SCAAR/SWEDEHEART study group (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp424 · Cited by 60
Routine Use of Bilateral Skeletonized Internal Thoracic Artery Grafting
Pevni, D., Uretzky, G., Mohr, A., Braunstein, R., Kramer, A., Paz, Y., Shapira, I., & Mohr, R. (2008) · Circulation · doi:10.1161/circulationaha.107.756676 · Cited by 58
Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Maron, D. J., Boden, W. E., Spertus, J. A., Hartigan, P. M., Mancini, G. B. J., Sedlis, S. P., Kostuk, W. J., CHAITMAN, B. R., Shaw, L. J., Berman, D. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.046 · Cited by 55
Off-Pump Bilateral Versus Single Skeletonized Internal Thoracic Artery Grafting in Patients With Diabetes
Kinoshita, T., Asai, T., Nishimura, O., Suzuki, T., Kambara, A., & Matsubayashi, K. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.05.048 · Cited by 54
Late Stent Thrombosis After Drug-Eluting Stent Implantation for Acute Myocardial Infarction
Pfisterer, M. E. (2008) · Circulation · doi:10.1161/circulationaha.108.803627 · Cited by 49
Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease
Dagenais, G. R., Lu, J., Faxon, D. P., Bogaty, P. M., Adler, D. S., Fuentes, F. J., Escobedo, J., Krishnaswami, A., Slater, J. N., & Frye, R. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.036 · Cited by 47
Diabetes Mellitus as a Predictor for Radial Artery Vasoreactivity in Patients Undergoing Coronary Artery Bypass Grafting
Choudhary, B. P., Antoniades, C. A., Brading, A. F., Galione, A., Channon, K. M., & Taggart, D. P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.008 · Cited by 46
Off-Pump Bilateral Versus Single Skeletonized Internal Thoracic Artery Grafting in High-Risk Patients
Kinoshita, T., Asai, T., Suzuki, T., Kambara, A., & Matsubayashi, K. (2011) · Circulation · doi:10.1161/circulationaha.110.010892 · Cited by 44
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Bianchi, C., Miccoli, R., Daniele, G., Penno, G., & Prato, S. D. (2009) · Diabetes Care · doi:10.2337/dc09-s336 · Cited by 40
Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity☆
D’Ancona, G., Bertuzzi, F., Sacchi, L., Pirone, F., Stringi, V., Arcadipane, A. F., Bellazzi, R., & Pilato, M. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.11.065 · Cited by 34
Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery
Kip, K. E., Alderman, E. L., Bourassa, M. G., Brooks, M. M., Schwartz, L., Holmes, D. R., Califf, R. M., Whitlow, P. L., CHAITMAN, B. R., & Detre, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000014967.78190.bb · Cited by 33
Compelling evidence for coronary-bypass surgery in patients with diabetes.
Hlatky, M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1212278 · Cited by 32
Surgery Is Preferred for the Diabetic With Multivessel Disease
King, S. B. (2005) · Circulation · doi:10.1161/circulationaha.104.483339 · Cited by 29
Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus
Singh, S. B., Bhat, J., & Wang, P. H. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0327-1 · Cited by 23
Diabetes Does Not Affect Long-Term Results After Total Arterial Off-Pump Coronary Revascularization
Hwang, H. Y., Choi, J. S., & Kim, K. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.05.021 · Cited by 18
Therapy Insight: diabetes and drug-eluting stents
Legrand, V. M. G. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0804 · Cited by 17
Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus
Aronson, D., & Edelman, E. R. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.01.011 · Cited by 7
Self-citation
Weighty Matters
Fox, C. S. (2012) · Circulation · doi:10.1161/circulationaha.112.152777 · Cited by 5

Sorted by citations

Nrf2 at the heart of oxidative stress and cardiac protection
Chen, Q. M., & Maltagliati, A. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2017 · Cited by 487
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 512
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, O. C., Steen, A., & Covașă, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 448
Cellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337
Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management
Alam, S., Hasan, M. K., Neaz, S., Hussain, N., Hossain, M. F., & Rahman, T. (2021) · Diabetology · doi:10.3390/diabetology2020004 · Cited by 384

See all 222

Authors: Aronson, D., & Edelman, E. R.
Affiliations: Technion – Israel Institute of Technology (IL)
Brigham and Women's Hospital (US)
ORCID: Aronson, Doron
Edelman, Elazer R.
Venue: Cardiology Clinics
Publisher: Elsevier BV
Published: 2014-08
Volume: 32
Issue: 3
Pages: 439-455
ISSN: 0733-8651 (ISSN-L)
DOI: 10.1016/j.ccl.2014.04.001
PMC: PMC4672945
OpenAlex: W2103962300
Cited by: 222
References: 125
Citations by year: 2026: 9 · 2025: 30 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 27 · 2020: 23 · 2019: 19 · 2018: 12 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 1
FWCI: 1.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cardiology Clinics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of General Medical Sciences (R01GM049039)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: coronary artery disease, diabetes mellitus, glycemic control, cardiovascular risk, coronary revascularization, coronary artery bypass grafting, percutaneous coronary intervention, multivessel coronary artery disease, heart team, optimal medical therapy
MeSH terms: Coronary Artery Disease, Diabetes Mellitus, Humans, Hypoglycemic Agents, Myocardial Revascularization, Risk Factors, Global Health, Incidence, Prevalence, Glycemic Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Coronary Artery Disease and Diabetes Mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks